Correlation Between Arvinas and Puma Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arvinas and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arvinas and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arvinas and Puma Biotechnology, you can compare the effects of market volatilities on Arvinas and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arvinas with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arvinas and Puma Biotechnology.

Diversification Opportunities for Arvinas and Puma Biotechnology

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Arvinas and Puma is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Arvinas and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Arvinas is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arvinas are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Arvinas i.e., Arvinas and Puma Biotechnology go up and down completely randomly.

Pair Corralation between Arvinas and Puma Biotechnology

Given the investment horizon of 90 days Arvinas is expected to generate 0.71 times more return on investment than Puma Biotechnology. However, Arvinas is 1.42 times less risky than Puma Biotechnology. It trades about -0.08 of its potential returns per unit of risk. Puma Biotechnology is currently generating about -0.06 per unit of risk. If you would invest  4,801  in Arvinas on August 25, 2024 and sell it today you would lose (2,215) from holding Arvinas or give up 46.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Arvinas  vs.  Puma Biotechnology

 Performance 
       Timeline  
Arvinas 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arvinas has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Arvinas is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Puma Biotechnology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Arvinas and Puma Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arvinas and Puma Biotechnology

The main advantage of trading using opposite Arvinas and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arvinas position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.
The idea behind Arvinas and Puma Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device